These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1565901)

  • 1. Markers of prognosis in superficial bladder cancer.
    Fradet Y
    Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical appraisal of tumor markers in bladder cancer.
    Fradet Y; Cordon-Cardo C
    Semin Urol; 1993 Aug; 11(3):145-53. PubMed ID: 8105526
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
    Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivariate analysis DNA/cytokeratin 7 and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications.
    Leonardi E; Cristofori A; Reich A; Dalla Palma P
    Eur J Histochem; 1997; 41 Suppl 2():133-4. PubMed ID: 9859817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on bladder cancer using flow cytometry. II. Evaluation of prognosis and intravesical recurrence of bladder cancer based on flow cytometric DNA analysis].
    Yoshikawa K; Tochigi T; Hoshi S; Orikasa S; Imai Y
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):227-31. PubMed ID: 3613331
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers and prognostic parameters in urinary bladder cancer].
    Schneider AW; Huland H
    Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA flow cytometry: an update of its use in assessing prognosis for transitional cell cancer of the bladder.
    Norming U
    Semin Urol; 1993 Aug; 11(3):154-63. PubMed ID: 8210836
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts.
    Aprikian AG; Sarkis AS; Reuter VE; Cordon-Cardo C; Sheinfeld J
    Semin Urol; 1993 Aug; 11(3):137-44. PubMed ID: 8210835
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance and application of DNA ploidy of bladder cancer cells in studying the malignancy of tumors].
    Cao S
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):143-5. PubMed ID: 2163740
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular markers for detection, surveillance and prognostication of bladder cancer.
    Vrooman OP; Witjes JA
    Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
    Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
    J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent diagnostic modalities for bladder cancer.
    Sheinfeld J; Cordon-Cardo C; Bander NH
    Immunol Ser; 1990; 53():485-97. PubMed ID: 2151621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular biology studies of bladder cancer].
    Bringuier PP; Knopf HJ; Schalken JA; Debruyne FM
    Urologe A; 1991 May; 30(3):167-71. PubMed ID: 1871935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.